Moderna Stock Explodes 140% as Cancer Vaccine Breakthrough Rewrites the MRNA Story
Shares more than doubled after Moderna and Merck’s personalized mRNA cancer vaccine delivered a major Phase 3 melanoma victory, potentially ...
Tag: MRNA
Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention
Biotech rally fueled by outbreak concerns, promising flu vaccine data, and potential FDA leadership changes Moderna (MRNA) shares climbed sharply ...
Moderna’s Flu Vaccine Back Under FDA Review After Key Modifications
Regulatory reversal boosts investor confidence and puts mRNA flu shot on track for potential approval this year Moderna (MRNA) has ...
Moderna Slashes 2025 Sales Forecast Amid Weak Vaccine Demand
Slow RSV shot adoption and waning COVID-19 vaccine sales weigh on revenue projections Moderna (MRNA) announced a $1 billion reduction ...
